{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T09:02:33Z","timestamp":1789635753855,"version":"4.0.0"},"reference-count":67,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T00:00:00Z","timestamp":1786492800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T00:00:00Z","timestamp":1786492800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100004410","name":"T\u00fcrkiye Bilimsel ve Teknolojik Ara\u015ft\u0131rma Kurumu","doi-asserted-by":"publisher","award":["1919B012105135"],"award-info":[{"award-number":["1919B012105135"]}],"id":[{"id":"10.13039\/501100004410","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Biochem Biophys"],"DOI":"10.1007\/s12013-026-02122-z","type":"journal-article","created":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T09:34:01Z","timestamp":1786527241000},"page":"4331-4346","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Selective Cytotoxic and Redox-Associated Effects of Plant-Derived Terpenoids in Human Glioblastoma Cells"],"prefix":"10.1007","volume":"84","author":[{"given":"Abdul Saltuk Bu\u011fra","family":"Da\u015f","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehmet Enes","family":"Arslan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8359-5649","authenticated-orcid":false,"given":"Murat","family":"Aydemir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdurrahim","family":"Kad\u0131","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taha","family":"Ayk\u0131l\u0131\u00e7","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Berk Can","family":"K\u00f6ksal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hasan","family":"T\u00fcrkez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,12]]},"reference":[{"issue":"Supplement_5","key":"2122_CR1","doi-asserted-by":"publisher","first-page":"v1","DOI":"10.1093\/neuonc\/noac202","volume":"24","author":"QT Ostrom","year":"2022","unstructured":"Ostrom, Q. T., Price, M., Neff, C., Cioffi, G., Waite, K. A., Kruchko, C., & Barnholtz-Sloan, J. S. (2022). CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2015\u20132019. Neuro-Oncology, 24(Supplement_5), v1\u2013v95. https:\/\/doi.org\/10.1093\/neuonc\/noac202","journal-title":"Neuro-Oncology"},{"issue":"10","key":"2122_CR2","doi-asserted-by":"publisher","first-page":"1919","DOI":"10.1007\/s00234-022-03008-6","volume":"64","author":"C McNamara","year":"2022","unstructured":"McNamara, C., Mankad, K., Thust, S., Dixon, L., Limback-Stanic, C., D\u2019Arco, F., & L\u00f6bel, U. (2022). 2021 WHO classification of tumours of the central nervous system: a review for the neuroradiologist. Neuroradiology, 64(10), 1919\u20131950. https:\/\/doi.org\/10.1007\/s00234-022-03008-6","journal-title":"Neuroradiology"},{"key":"2122_CR3","doi-asserted-by":"publisher","unstructured":"Tali, T. A., Amin, F., Sofi, S. R., Sofi, M. A., & Dar, N. A. (2023). Epidemiology and outcome of glioblastoma multiforme: A tertiary care experience. Asian Journal of Oncology, 9. https:\/\/doi.org\/10.25259\/ASJO-2022-65-(429)","DOI":"10.25259\/ASJO-2022-65-(429)"},{"issue":"7","key":"2122_CR4","doi-asserted-by":"publisher","first-page":"95","DOI":"10.3978\/j.issn.2305-5839.2015.03.57","volume":"3","author":"K Vigneswaran","year":"2015","unstructured":"Vigneswaran, K., Neill, S., & Hadjipanayis, C. G. (2015). Beyond the World Health Organization grading of infiltrating gliomas: advances in the molecular genetics of glioma classification. Annals of Translational Medicine, 3(7), 95. https:\/\/doi.org\/10.3978\/j.issn.2305-5839.2015.03.57","journal-title":"Annals of Translational Medicine"},{"issue":"11","key":"2122_CR5","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1007\/s12094-016-1497-x","volume":"18","author":"PD Delgado-L\u00f3pez","year":"2016","unstructured":"Delgado-L\u00f3pez, P. D., & Corrales-Garc\u00eda, E. M. (2016). Survival in glioblastoma: a review on the impact of treatment modalities. Clinical and Translational Oncology, 18(11), 1062\u20131071. https:\/\/doi.org\/10.1007\/s12094-016-1497-x","journal-title":"Clinical and Translational Oncology"},{"issue":"7","key":"2122_CR6","doi-asserted-by":"publisher","first-page":"1448","DOI":"10.1093\/annonc\/mdx169","volume":"28","author":"MA Qazi","year":"2017","unstructured":"Qazi, M. A., Vora, P., Venugopal, C., Sidhu, S. S., Moffat, J., Swanton, C., & Singh, S. K. (2017). Intratumoral heterogeneity: pathways to treatment resistance and relapse in human glioblastoma. Annals of Oncology, 28(7), 1448\u20131456. https:\/\/doi.org\/10.1093\/annonc\/mdx169","journal-title":"Annals of Oncology"},{"key":"2122_CR7","doi-asserted-by":"publisher","unstructured":"Ron\u010devi\u0107, A., Koruga, N., Koruga, A. S., & Ron\u010devi\u0107, R. (2025). Why Do Glioblastoma Treatments Fail? Future Pharmacology, 5(1). https:\/\/doi.org\/10.3390\/futurepharmacol5010007","DOI":"10.3390\/futurepharmacol5010007"},{"key":"2122_CR8","doi-asserted-by":"publisher","unstructured":"Tilak, M., Holborn, J., New, L. A., Lalonde, J., & Jones, N. (2021). Receptor Tyrosine Kinase Signaling and Targeting in Glioblastoma Multiforme. International Journal of Molecular Sciences, 22(4). https:\/\/doi.org\/10.3390\/ijms22041831","DOI":"10.3390\/ijms22041831"},{"issue":"11","key":"2122_CR9","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1002\/cac2.12361","volume":"42","author":"E Verdugo","year":"2022","unstructured":"Verdugo, E., Puerto, I., & Medina, M. \u00c1. (2022). An update on the molecular biology of glioblastoma, with clinical implications and progress in its treatment. Cancer Communications, 42(11), 1083\u20131111. https:\/\/doi.org\/10.1002\/cac2.12361","journal-title":"Cancer Communications"},{"key":"2122_CR10","doi-asserted-by":"publisher","unstructured":"Olivier, C., Oliver, L., Lalier, L., & Vallette, F. M. (2021). Drug Resistance in Glioblastoma: The Two Faces of Oxidative Stress. Frontiers in Molecular Biosciences, 7. https:\/\/doi.org\/10.3389\/fmolb.2020.620677","DOI":"10.3389\/fmolb.2020.620677"},{"key":"2122_CR11","doi-asserted-by":"publisher","unstructured":"Singh, S., Dey, D., Barik, D., Mohapatra, I., Kim, S., Sharma, M., \u2026 Singh, G. (2025).Glioblastoma at the crossroads: current understanding and future therapeutic horizons.Signal Transduction and Targeted Therapy, 10(1), 213. https:\/\/doi.org\/10.1038\/s41392-025-02299-4.","DOI":"10.1038\/s41392-025-02299-4."},{"key":"2122_CR12","doi-asserted-by":"publisher","unstructured":"Salazar-Ramiro, A., Ram\u00edrez-Ortega, D., P\u00e9rez de la Cruz, V., H\u00e9rnandez-PedroN. Y., Gonz\u00e1lez-Esquivel, D. F., Sotelo, J., & Pineda, B. (2016). Role of Redox Status in Development of Glioblastoma. Frontiers in Immunology, 7. https:\/\/doi.org\/10.3389\/fimmu.2016.00156","DOI":"10.3389\/fimmu.2016.00156"},{"issue":"2","key":"2122_CR13","doi-asserted-by":"publisher","first-page":"119573","DOI":"10.1016\/j.bbamcr.2023.119573","volume":"1871","author":"D Averill-Bates","year":"2024","unstructured":"Averill-Bates, D. (2024). Reactive oxygen species and cell signaling. Review. Biochimica et Biophysica Acta (BBA) -. Molecular Cell Research, 1871(2), 119573. https:\/\/doi.org\/10.1016\/j.bbamcr.2023.119573","journal-title":"Molecular Cell Research"},{"issue":"10","key":"2122_CR14","doi-asserted-by":"publisher","first-page":"2499","DOI":"10.1007\/s00204-023-03562-9","volume":"97","author":"K Jomova","year":"2023","unstructured":"Jomova, K., Raptova, R., Alomar, S. Y., Alwasel, S. H., Nepovimova, E., Kuca, K., & Valko, M. (2023). Reactive oxygen species, toxicity, oxidative stress, and antioxidants: chronic diseases and aging. Archives of Toxicology, 97(10), 2499\u20132574. https:\/\/doi.org\/10.1007\/s00204-023-03562-9","journal-title":"Archives of Toxicology"},{"issue":"3","key":"2122_CR15","doi-asserted-by":"publisher","first-page":"287","DOI":"10.20517\/cdr.2020.29","volume":"3","author":"L Oliver","year":"2020","unstructured":"Oliver, L., Lalier, L., Salaud, C., Heymann, D., Cartron, P. F., & Vallette, F. M. (2020). Drug resistance in glioblastoma: are persisters the key to therapy? Cancer Drug Resistance, 3(3), 287\u2013301. https:\/\/doi.org\/10.20517\/cdr.2020.29","journal-title":"Cancer Drug Resistance"},{"issue":"5","key":"2122_CR16","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1093\/neuonc\/noab269","volume":"24","author":"YA Yabo","year":"2022","unstructured":"Yabo, Y. A., Niclou, S. P., & Golebiewska, A. (2022). Cancer cell heterogeneity and plasticity: A paradigm shift in glioblastoma. Neuro-Oncology, 24(5), 669\u2013682. https:\/\/doi.org\/10.1093\/neuonc\/noab269","journal-title":"Neuro-Oncology"},{"key":"2122_CR17","doi-asserted-by":"publisher","unstructured":"Friedmann-Morvinski, D. (2014). Glioblastoma Heterogeneity and Cancer Cell Plasticity. Critical Reviews\u2122 in Oncogenesis, 19(5). https:\/\/doi.org\/10.1615\/CritRevOncog.2014011777","DOI":"10.1615\/CritRevOncog.2014011777"},{"key":"2122_CR18","doi-asserted-by":"publisher","unstructured":"Davis, M. E. (2016). Glioblastoma: Overview of Disease and Treatment. Clinical Journal of Oncology Nursing, 20(5 Suppl). https:\/\/doi.org\/10.1188\/16.CJON.S1.2-8. S2-8.","DOI":"10.1188\/16.CJON.S1.2-8"},{"issue":"4","key":"2122_CR19","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1007\/s13402-022-00684-7","volume":"45","author":"C Boccellato","year":"2022","unstructured":"Boccellato, C., & Rehm, M. (2022). Glioblastoma, from disease understanding towards optimal cell-based in vitro models. Cellular Oncology, 45(4), 527\u2013541. https:\/\/doi.org\/10.1007\/s13402-022-00684-7","journal-title":"Cellular Oncology"},{"key":"2122_CR20","doi-asserted-by":"publisher","first-page":"156","DOI":"10.3389\/fimmu.2016.00156","volume":"7","author":"A Salazar-Ramiro","year":"2016","unstructured":"Salazar-Ramiro, A., Ram\u00edrez-Ortega, D., de la P\u00e9rez, V., H\u00e9rnandez-Pedro, N. Y., Gonz\u00e1lez-Esquivel, D. F., Sotelo, J., & Pineda, B. (2016). Role of Redox Status in Development of Glioblastoma. Frontiers in Immunology, 7, 156. https:\/\/doi.org\/10.3389\/fimmu.2016.00156","journal-title":"Frontiers in Immunology"},{"key":"2122_CR21","doi-asserted-by":"publisher","unstructured":"Nowacka, A., \u015aniegocki, M., & Zi\u00f3\u0142kowska, E. (2025). Oxidative Stress and Antioxidants in Glioblastoma: Mechanisms of Action, Therapeutic Effects and Future Directions. Antioxidants, 14(9). https:\/\/doi.org\/10.3390\/antiox14091121","DOI":"10.3390\/antiox14091121"},{"issue":"1","key":"2122_CR22","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1186\/s12935-021-02099-0","volume":"21","author":"A Arabzadeh","year":"2021","unstructured":"Arabzadeh, A., Mortezazadeh, T., Aryafar, T., Gharepapagh, E., Majdaeen, M., & Farhood, B. (2021). Therapeutic potentials of resveratrol in combination with radiotherapy and chemotherapy during glioblastoma treatment: a mechanistic review. Cancer Cell International, 21(1), 391. https:\/\/doi.org\/10.1186\/s12935-021-02099-0","journal-title":"Cancer Cell International"},{"issue":"10","key":"2122_CR23","doi-asserted-by":"publisher","first-page":"1985","DOI":"10.1158\/1055-9965.EPI-14-0275","volume":"23","author":"JP Thakkar","year":"2014","unstructured":"Thakkar, J. P., Dolecek, T. A., Horbinski, C., Ostrom, Q. T., Lightner, D. D., Barnholtz-Sloan, J. S., & Villano, J. L. (2014). Epidemiologic and molecular prognostic review of glioblastoma. Cancer Epidemiology Biomarkers & Prevention: A Publication of the American Association for Cancer Research Cosponsored by the American Society of Preventive Oncology, 23(10), 1985\u20131996. https:\/\/doi.org\/10.1158\/1055-9965.EPI-14-0275","journal-title":"Cancer Epidemiology Biomarkers & Prevention: A Publication of the American Association for Cancer Research Cosponsored by the American Society of Preventive Oncology"},{"issue":"8","key":"2122_CR24","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1038\/nrneurol.2011.100","volume":"7","author":"G Riddick","year":"2011","unstructured":"Riddick, G., & Fine, H. A. (2011). Integration and analysis of genome-scale data from gliomas. Nature Reviews Neurology, 7(8), 439\u2013450. https:\/\/doi.org\/10.1038\/nrneurol.2011.100","journal-title":"Nature Reviews Neurology"},{"key":"2122_CR25","doi-asserted-by":"publisher","unstructured":"McLendon, R., Friedman, A., Bigner, D., Van Meir, E. G., Brat, D. J., M. Mastrogianakis,G., \u2026 National Human Genome Research Institute. (2008). Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature, 455(7216), 1061\u20131068. https:\/\/doi.org\/10.1038\/nature07385.","DOI":"10.1038\/nature07385."},{"key":"2122_CR26","doi-asserted-by":"publisher","first-page":"913328","DOI":"10.3389\/fnmol.2022.913328","volume":"15","author":"R Li","year":"2022","unstructured":"Li, R., Jiang, Q., Tang, C., Chen, L., Kong, D., Zou, C., & Zou, D. (2022). Identification of Candidate Genes Associated With Prognosis in Glioblastoma. Frontiers in Molecular Neuroscience, 15, 913328. https:\/\/doi.org\/10.3389\/fnmol.2022.913328","journal-title":"Frontiers in Molecular Neuroscience"},{"key":"2122_CR27","doi-asserted-by":"publisher","first-page":"1166","DOI":"10.3389\/fpls.2019.01166","volume":"10","author":"PS Karunanithi","year":"2019","unstructured":"Karunanithi, P. S., & Zerbe, P. (2019). Terpene Synthases as Metabolic Gatekeepers in the Evolution of Plant Terpenoid Chemical Diversity. Frontiers in Plant Science, 10, 1166. https:\/\/doi.org\/10.3389\/fpls.2019.01166","journal-title":"Frontiers in Plant Science"},{"issue":"1","key":"2122_CR28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00425-018-3056-x","volume":"249","author":"SD Tetali","year":"2019","unstructured":"Tetali, S. D. (2019). Terpenes and isoprenoids: a wealth of compounds for global use. Planta, 249(1), 1\u20138. https:\/\/doi.org\/10.1007\/s00425-018-3056-x","journal-title":"Planta"},{"key":"2122_CR29","doi-asserted-by":"publisher","unstructured":"Tholl, D. (2015). Biosynthesis and Biological Functions of Terpenoids in Plants. In J. Schrader, & J. Bohlmann (Eds.), Biotechnology of Isoprenoids (pp. 63\u2013106). Springer International Publishing. https:\/\/doi.org\/10.1007\/10_2014_295","DOI":"10.1007\/10_2014_295"},{"key":"2122_CR30","doi-asserted-by":"publisher","unstructured":"Masyita, A., Mustika Sari, R., Dwi Astuti, A., Yasir, B., Rahma Rumata, N., Emran,T. B., \u2026 Simal-Gandara, J. (2022). Terpenes and terpenoids as main bioactive compounds of essential oils, their roles in human health and potential application as natural food preservatives. Food Chemistry: X, 13, 100217. https:\/\/doi.org\/10.1016\/j.fochx.2022.100217.","DOI":"10.1016\/j.fochx.2022.100217."},{"issue":"9","key":"2122_CR31","doi-asserted-by":"publisher","first-page":"228","DOI":"10.4254\/wjh.v3.i9.228","volume":"3","author":"RJ Thoppil","year":"2011","unstructured":"Thoppil, R. J., & Bishayee, A. (2011). Terpenoids as potential chemopreventive and therapeutic agents in liver cancer. World Journal of Hepatology, 3(9), 228\u2013249. https:\/\/doi.org\/10.4254\/wjh.v3.i9.228","journal-title":"World Journal of Hepatology"},{"issue":"27","key":"2122_CR32","doi-asserted-by":"publisher","first-page":"3162","DOI":"10.2174\/0929867325666180214110932","volume":"25","author":"SB Ateba","year":"2018","unstructured":"Ateba, S. B., Mvondo, M. A., Ngeu, S. T., Tchoumtchoua, J., Awounfack, C. F., Njamen, D., & Krenn, L. (2018). Natural Terpenoids Against Female Breast Cancer: A 5-year Recent Research. Current Medicinal Chemistry, 25(27), 3162\u20133213. https:\/\/doi.org\/10.2174\/0929867325666180214110932","journal-title":"Current Medicinal Chemistry"},{"key":"2122_CR33","doi-asserted-by":"publisher","unstructured":"Kamran, S., Sinniah, A., Abdulghani, M. A. M., & Alshawsh, M. A. (2022). Therapeutic Potential of Certain Terpenoids as Anticancer Agents: A Scoping Review. Cancers, 14(5). https:\/\/doi.org\/10.3390\/cancers14051100","DOI":"10.3390\/cancers14051100"},{"key":"2122_CR34","doi-asserted-by":"publisher","unstructured":"Khan, F., Pandey, P., Verma, M., & Upadhyay, T. K. (2024). Terpenoid-Mediated Targeting of STAT3 Signaling in Cancer: An Overview of Preclinical Studies. Biomolecules, 14(2). https:\/\/doi.org\/10.3390\/biom14020200","DOI":"10.3390\/biom14020200"},{"issue":"5","key":"2122_CR35","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1007\/s43440-023-00512-1","volume":"75","author":"P Wr\u00f3blewska-\u0141uczka","year":"2023","unstructured":"Wr\u00f3blewska-\u0141uczka, P., Cabaj, J., Bargie\u0142, J., & \u0141uszczki, J. J. (2023). Anticancer effect of terpenes: focus on malignant melanoma. Pharmacological Reports, 75(5), 1115\u20131125. https:\/\/doi.org\/10.1007\/s43440-023-00512-1","journal-title":"Pharmacological Reports"},{"key":"2122_CR36","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1016\/j.biopha.2017.10.124","volume":"97","author":"V Kaur","year":"2018","unstructured":"Kaur, V., Kumar, M., Kumar, A., Kaur, K., Dhillon, V. S., & Kaur, S. (2018). Pharmacotherapeutic potential of phytochemicals: Implications in cancer chemoprevention and future perspectives. Biomedicine & Pharmacotherapy\u2009=\u2009Biomedecine & Pharmacotherapie, 97, 564\u2013586. https:\/\/doi.org\/10.1016\/j.biopha.2017.10.124","journal-title":"Biomedicine & Pharmacotherapy\u2009=\u2009Biomedecine & Pharmacotherapie"},{"issue":"9","key":"2122_CR37","doi-asserted-by":"publisher","first-page":"228","DOI":"10.4254\/wjh.v3.i9.228","volume":"3","author":"RJ Thoppil","year":"2011","unstructured":"Thoppil, R. J., & Bishayee, A. (2011). Terpenoids as potential chemopreventive and therapeutic agents in liver cancer. World Journal of Hepatology, 3(9), 228\u2013249. https:\/\/doi.org\/10.4254\/wjh.v3.i9.228","journal-title":"World Journal of Hepatology"},{"key":"2122_CR38","doi-asserted-by":"publisher","unstructured":"C\u00e2mara, J. S., Perestrelo, R., Ferreira, R., Berenguer, C. V., Pereira, J. A. M., & Castilho, P. C. (2024). Plant-Derived Terpenoids: A Plethora of Bioactive Compounds with Several Health Functions and Industrial Applications\u2014A Comprehensive Overview. Molecules, 29(16). https:\/\/doi.org\/10.3390\/molecules29163861","DOI":"10.3390\/molecules29163861"},{"key":"2122_CR39","doi-asserted-by":"publisher","unstructured":"Abdulsalam, R. A., Lukman, H. Y., & Sabiu, S. (2025). Phenolics and Terpenoids in Nanostructures for Biomedicine. Natural Products (pp. 1\u201322). Springer. https:\/\/doi.org\/10.1007\/978-3-642-36202-6_254-1","DOI":"10.1007\/978-3-642-36202-6_254-1"},{"key":"2122_CR40","doi-asserted-by":"publisher","unstructured":"Singh, K., Bano, A., Sharma, R., & Sharma, S. (2023). Terpenoids in Nanomaterials: Synthesis, Characterization, and Their Application. In A. Husen (Ed.), Secondary Metabolites Based Green Synthesis of Nanomaterials and Their Applications (pp. 91\u2013118). Springer Nature. https:\/\/doi.org\/10.1007\/978-981-99-0927-8_5","DOI":"10.1007\/978-981-99-0927-8_5"},{"issue":"4","key":"2122_CR41","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1007\/s43450-022-00285-3","volume":"32","author":"V Rani","year":"2022","unstructured":"Rani, V., R, S., P., & Prabhu, A. (2022). Nutraceuticals Derived from Dietary Spices as Candidate Molecules in Targeting Glioma Signaling Pathways. Revista Brasileira de Farmacognosia, 32(4), 514\u2013526. https:\/\/doi.org\/10.1007\/s43450-022-00285-3","journal-title":"Revista Brasileira de Farmacognosia"},{"key":"2122_CR42","doi-asserted-by":"publisher","unstructured":"Perna, S., Alawadhi, H., Riva, A., Allegrini, P., Petrangolini, G., Gasparri, C., & Rondanelli, M. (2022). In Vitro and In Vivo Anticancer Activity of Basil (Ocimum spp.): Current Insights and Future Prospects. Cancers, 14(10). https:\/\/doi.org\/10.3390\/cancers14102375","DOI":"10.3390\/cancers14102375"},{"key":"2122_CR43","doi-asserted-by":"publisher","unstructured":"Chakraborty, S., Dhibar, M., Das, A., Swain, K., & Pattnaik, S. (2023). Biological Potential of Essential Oils. Essential Oils (pp. 521\u2013549). John Wiley & Sons, Ltd. https:\/\/doi.org\/10.1002\/9781119829614.ch23","DOI":"10.1002\/9781119829614.ch23"},{"key":"2122_CR44","doi-asserted-by":"publisher","unstructured":"Almeida, K. C. R., Silva, B. B., Alves, C. C. F., Vieira, T. M., Crotti, A. E. M.,Souza, J. M., \u2026 Miranda, M. L. D. (2020). Biological properties and chemical composition of essential oil from Nectandra megapotamica (Spreng.) Mez. leaves (Lauraceae). Natural Product Research, 34(21), 3149\u20133153. https:\/\/doi.org\/10.1080\/14786419.2019.1608539.","DOI":"10.1080\/14786419.2019.1608539."},{"issue":"7","key":"2122_CR45","doi-asserted-by":"publisher","first-page":"12757","DOI":"10.3390\/molecules200712757","volume":"20","author":"V Ponci","year":"2015","unstructured":"Ponci, V., Figueiredo, C. R., Massaoka, M. H., Farias, C. F. D., Matsuo, A. L., Sartorelli, P., & Lago, J. H. G (2015). Neolignans from Nectandra megapotamica (Lauraceae) Display in vitro Cytotoxic Activity and Induce Apoptosis in Leukemia Cells. Molecules, 20(7), 12757\u201312768. https:\/\/doi.org\/10.3390\/molecules200712757","journal-title":"Molecules"},{"issue":"1","key":"2122_CR46","doi-asserted-by":"publisher","first-page":"133","DOI":"10.3109\/13880209.2014.912238","volume":"53","author":"S dos S. Grecco","year":"2015","unstructured":"dos S. Grecco, S., Martins, E. G. A., Girola, N., de Figueiredo, C. R., Matsuo, A. L., Soares, M. G., & Lago, J. H. G. (2015). Chemical composition and in vitro cytotoxic effects of the essential oil from Nectandra leucantha leaves. Pharmaceutical Biology, 53(1), 133\u2013137. https:\/\/doi.org\/10.3109\/13880209.2014.912238","journal-title":"Pharmaceutical Biology"},{"issue":"13","key":"2122_CR47","doi-asserted-by":"publisher","first-page":"2367","DOI":"10.2174\/1871520622666211221144739","volume":"22","author":"S Datta","year":"2022","unstructured":"Datta, S., Luthra, R., & Bharadvaja, N. (2022). Medicinal Plants for Glioblastoma Treatment. Anti-Cancer Agents in Medicinal Chemistry, 22(13), 2367\u20132384. https:\/\/doi.org\/10.2174\/1871520622666211221144739","journal-title":"Anti-Cancer Agents in Medicinal Chemistry"},{"key":"2122_CR48","doi-asserted-by":"publisher","unstructured":"Yang, Y., More, S., De Smet, F., De Vleeschouwer, S., & Agostinis, P. (2024). Antioxidant network-based signatures cluster glioblastoma into distinct redox-resistant phenotypes. Frontiers in Immunology, 15. https:\/\/doi.org\/10.3389\/fimmu.2024.1342977","DOI":"10.3389\/fimmu.2024.1342977"},{"key":"2122_CR49","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1016\/j.freeradbiomed.2025.08.059","volume":"240","author":"Y Yuan","year":"2025","unstructured":"Yuan, Y., Li, J., Wang, M., Yuan, Q., Liu, Y., Yang, W., & Chen, M. (2025). Redox regulator LanCL1 suppresses glioma progression by coordinately inhibiting cell growth and regulating mitochondrial metabolism. Free Radical Biology and Medicine, 240, 559\u2013565. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2025.08.059","journal-title":"Free Radical Biology and Medicine"},{"key":"2122_CR50","doi-asserted-by":"publisher","unstructured":"Singh, S., Dey, D., Barik, D., Mohapatra, I., Kim, S., Sharma, M., \u2026 Singh, G. (2025).Glioblastoma at the crossroads: current understanding and future therapeutic horizons.Signal Transduction and Targeted Therapy, 10(1), 213. https:\/\/doi.org\/10.1038\/s41392-025-02299-4.","DOI":"10.1038\/s41392-025-02299-4."},{"key":"2122_CR51","doi-asserted-by":"publisher","unstructured":"Nowacka, A., \u015aniegocki, M., & Zi\u00f3\u0142kowska, E. (2025). Oxidative Stress and Antioxidants in Glioblastoma: Mechanisms of Action, Therapeutic Effects and Future Directions. Antioxidants, 14(9). https:\/\/doi.org\/10.3390\/antiox14091121","DOI":"10.3390\/antiox14091121"},{"key":"2122_CR52","doi-asserted-by":"publisher","unstructured":"Liaudanskas, M., \u017dvikas, V., & Petrikait\u0117, V. (2021). The Potential of Dietary Antioxidants from a Series of Plant Extracts as Anticancer Agents against Melanoma, Glioblastoma, and Breast Cancer. Antioxidants, 10(7). https:\/\/doi.org\/10.3390\/antiox10071115","DOI":"10.3390\/antiox10071115"},{"key":"2122_CR53","doi-asserted-by":"publisher","unstructured":"Taibi, M., Elbouzidi, A., Ouahhoud, S., Loukili, E. H., Ou-Yahya, D., Ouahabi, S., & Chaabane, K. (2023). Evaluation of Antioxidant Activity, Cytotoxicity, and Genotoxicity of Ptychotis verticillata Essential Oil: Towards Novel Breast Cancer Therapeutics. Life, 13(7). https:\/\/doi.org\/10.3390\/life13071586","DOI":"10.3390\/life13071586"},{"key":"2122_CR54","doi-asserted-by":"publisher","unstructured":"Hashem, S., Ali, T. A., Akhtar, S., Nisar, S., Sageena, G., Ali, S., \u2026 Bhat, A. A.(2022). Targeting cancer signaling pathways by natural products: Exploring promising anti-cancer agents. Biomedicine & Pharmacotherapy\u2009=\u2009Biomedecine & Pharmacotherapie, 150, 113054. https:\/\/doi.org\/10.1016\/j.biopha.2022.113054.","DOI":"10.1016\/j.biopha.2022.113054."},{"key":"2122_CR55","doi-asserted-by":"publisher","unstructured":"Alves, C., & Diederich, M. (2023). Marine Natural Products as Anticancer Agents 2.0. Marine Drugs, 21(4). https:\/\/doi.org\/10.3390\/md21040247","DOI":"10.3390\/md21040247"},{"issue":"23","key":"2122_CR56","doi-asserted-by":"publisher","first-page":"8367","DOI":"10.3390\/molecules27238367","volume":"27","author":"A Naeem","year":"2022","unstructured":"Naeem, A., Hu, P., Yang, M., Zhang, J., Liu, Y., Zhu, W., & Zheng, Q. (2022). Natural Products as Anticancer Agents: Current Status and Future Perspectives. Molecules, 27(23), 8367. https:\/\/doi.org\/10.3390\/molecules27238367","journal-title":"Molecules"},{"issue":"4","key":"2122_CR57","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1111\/cas.16086","volume":"115","author":"M Abe","year":"2024","unstructured":"Abe, M., Asada, N., Kimura, M., Fukui, C., Yamada, D., Wang, Z., & Maeda, Y. (2024). Antitumor activity of \u03b1-pinene in T-cell tumors. Cancer Science, 115(4), 1317\u20131332. https:\/\/doi.org\/10.1111\/cas.16086","journal-title":"Cancer Science"},{"issue":"3","key":"2122_CR58","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1080\/01635581.2014.884230","volume":"66","author":"PB Patel","year":"2014","unstructured":"Patel, P. B., & Thakkar, V. R. (2014). L-carvone induces p53, caspase 3 mediated apoptosis and inhibits the migration of breast cancer cell lines. Nutrition and Cancer, 66(3), 453\u2013462. https:\/\/doi.org\/10.1080\/01635581.2014.884230","journal-title":"Nutrition and Cancer"},{"issue":"9","key":"2122_CR59","doi-asserted-by":"publisher","first-page":"2757","DOI":"10.1007\/s11756-021-00803-z","volume":"76","author":"C Kig","year":"2021","unstructured":"Kig, C., Mertoglu, E., Caliskan, A., Hincal Agus, H., Ucar, O., E., & Guler, V. (2021). Selective and oxidative stress-mediated cell death of MCF-7 cell line induced by terpinolene. Biologia, 76(9), 2757\u20132766. https:\/\/doi.org\/10.1007\/s11756-021-00803-z","journal-title":"Biologia"},{"issue":"3","key":"2122_CR60","doi-asserted-by":"publisher","first-page":"415","DOI":"10.2478\/10004-1254-64-2013-2365","volume":"64","author":"E Aydin","year":"2013","unstructured":"Aydin, E., T\u00fcrkez, H., & Ta\u015fdemir, S. (2013). Anticancer and antioxidant properties of terpinolene in rat brain cells. Arhiv Za Higijenu Rada I Toksikologiju, 64(3), 415\u2013424. https:\/\/doi.org\/10.2478\/10004-1254-64-2013-2365","journal-title":"Arhiv Za Higijenu Rada I Toksikologiju"},{"key":"2122_CR61","doi-asserted-by":"publisher","first-page":"105780","DOI":"10.1016\/j.phrs.2021.105780","volume":"171","author":"W Wu","year":"2021","unstructured":"Wu, W., Klockow, J. L., Zhang, M., Lafortune, F., Chang, E., Jin, L., & Daldrup-Link, H. E. (2021). Glioblastoma multiforme (GBM): An overview of current therapies and mechanisms of resistance. Pharmacological Research, 171, 105780. https:\/\/doi.org\/10.1016\/j.phrs.2021.105780","journal-title":"Pharmacological Research"},{"key":"2122_CR62","doi-asserted-by":"publisher","unstructured":"Ardizzone, A., Scuderi, S. A., Giuffrida, D., Colarossi, C., Puglisi, C., Campolo,M., \u2026 Paterniti, I. (2020). Role of Fibroblast Growth Factors Receptors (FGFRs) in Brain Tumors, Focus on Astrocytoma and Glioblastoma. Cancers, 12(12). https:\/\/doi.org\/10.3390\/cancers12123825.","DOI":"10.3390\/cancers12123825."},{"key":"2122_CR63","doi-asserted-by":"publisher","unstructured":"Jimenez-Pascual, A., & Siebzehnrubl, F. A. (2019). Fibroblast Growth Factor Receptor Functions in Glioblastoma. Cells, 8(7). https:\/\/doi.org\/10.3390\/cells8070715","DOI":"10.3390\/cells8070715"},{"issue":"1","key":"2122_CR64","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1038\/s41392-020-00222-7","volume":"5","author":"Y Xie","year":"2020","unstructured":"Xie, Y., Su, N., Yang, J., Tan, Q., Huang, S., Jin, M., & Chen, L. (2020). FGF\/FGFR signaling in health and disease. Signal Transduction and Targeted Therapy, 5(1), 181. https:\/\/doi.org\/10.1038\/s41392-020-00222-7","journal-title":"Signal Transduction and Targeted Therapy"},{"key":"2122_CR65","doi-asserted-by":"publisher","unstructured":"Karunanithi, P. S., & Zerbe, P. (2019). Terpene Synthases as Metabolic Gatekeepers in the Evolution of Plant Terpenoid Chemical Diversity. Frontiers in Plant Science, 10. https:\/\/doi.org\/10.3389\/fpls.2019.01166","DOI":"10.3389\/fpls.2019.01166"},{"issue":"3","key":"2122_CR66","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1039\/C9NP00051H","volume":"37","author":"JD Rudolf","year":"2020","unstructured":"Rudolf, J. D., & Chang, C. Y. (2020). Terpene synthases in disguise: enzymology, structure, and opportunities of non-canonical terpene synthases. Natural Product Reports, 37(3), 425\u2013463. https:\/\/doi.org\/10.1039\/C9NP00051H","journal-title":"Natural Product Reports"},{"key":"2122_CR67","doi-asserted-by":"publisher","unstructured":"Wei, G., Xu, Y., Xu, M., Shi, X., Wang, J., & Feng, L. (2024). Identification of Volatile Compounds and Terpene Synthase (TPS) Genes Reveals ZcTPS02 Involved in \u03b2-Ocimene Biosynthesis in Zephyranthes candida. Genes, 15(2). https:\/\/doi.org\/10.3390\/genes15020185","DOI":"10.3390\/genes15020185"}],"container-title":["Cell Biochemistry and Biophysics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12013-026-02122-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12013-026-02122-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12013-026-02122-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T08:16:17Z","timestamp":1789632977000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12013-026-02122-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,12]]},"references-count":67,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2026,9]]}},"alternative-id":["2122"],"URL":"https:\/\/doi.org\/10.1007\/s12013-026-02122-z","relation":{},"ISSN":["1559-0283"],"issn-type":[{"value":"1559-0283","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,12]]},"assertion":[{"value":"7 July 2026","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 August 2026","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Conflict of Interest","group":{"name":"EthicsHeading","label":"Declarations"}}]}}